About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Rule Out Heart Attacks Instantly With the New Portable Device

by Rishika Gupta on June 5, 2018 at 12:18 PM
Font : A-A+

 Rule Out Heart Attacks Instantly With the New Portable Device

Heart attacks can be diagnosed instantly with the help of a new cardiac myosin-binding protein C (cMyC) portable blood test device. Levels of cMyC have been found to rise after a heart attack, even to a greater extent than troponin. This principle in itself can rule out heart attacks instantly in a lot of people.

A new blood test being developed to diagnose heart attacks could one day be carried out on a simple handheld device, giving a rapid diagnosis in A&E departments without the need for samples to be sent to a lab, according to new research presented today at the British Cardiovascular Society Conference in Manchester.

Advertisement


The new test uses similar technology to the troponin test but analyses the level of a protein called cardiac myosin-binding protein C (cMyC). Levels of cMyC in the blood increase more rapidly after a heart attack, and to a greater extent than troponin, meaning that the test can rule out a heart attack in a higher proportion of patients straight away.

The international team, part-funded by the British Heart Foundation, took blood from 776 patients traveling to the hospital by ambulance in Denmark. Researchers based at King's College London then tested these samples for cMyC protein.
Advertisement

In patients who did suffer heart attacks, the protein was present in high enough concentrations 95 percent of the time for an on-the-spot diagnosis. Importantly, the cMyC test outperformed the existing troponin test, which was only capable of diagnosing around 40 percent of patients in this way. This is mainly because troponin takes longer to reach detectable levels in the blood after you suffer a heart attack.

The researchers now hope to work with industry to create a portable testing device to be used in UK A&E departments, and in ambulances in countries where these have to drive considerable distances to get patients to their nearest hospital. A simple handheld device could replace the time-consuming processes involved in sending samples to the hospital labs for analysis.

It is estimated that over two-thirds of people who attend A&E complaining of chest pain have not had a heart attack. But all will receive two tests: a heart test called an ECG and a blood test to measure the levels of a protein called troponin.

Under current guidelines, people suspected of having a heart attack are tested for high blood troponin levels as soon as they arrive in an A&E, and again after three hours. Depending on the type of troponin test used, up to 85 percent of people will need to remain in the hospital for further tests in order to rule out a heart attack.

The cMyC blood test, developed by a team from King's College London and tested across Europe, has already been shown to rapidly rule out a heart attack in more people than the standard troponin test. This could reassure worried patients in A&E departments, free up bed space and save hundreds of thousands of pounds per UK hospital every year.

Dr. Tom Kaier, one of the lead researchers, funded by the British Heart Foundation at St Thomas' Hospital, London said: "It is important for both patients and doctors to work out early who has had a heart attack and who hasn't."

"Now that we know that this test is sensitive enough to give an almost immediate heart attack diagnosis, we need to work on developing a testing device. We'd love to see this used in A&E departments within the next five years," said Dr. Kaiser.

Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation, said:

"Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging. The troponin test has been used for around 20 years and is currently the most powerful tool we have for diagnosing such heart attacks, but there is always room for improvement.

"These initial results with the cMyC test look very promising for patients, who could be more quickly diagnosed and treated or reassured and sent home. However, further research is necessary before it can be recommended as a replacement for the troponin test."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
First Dose of COVID-19 Vaccines May Improve Mental Health
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Heart Healthy Heart Statins Mitral Valve Prolapse Aortic Valve Stenosis Pericarditis 

Recommended Reading
Current Standards to Detect Heart Attacks may Not be Attack Proof
Cardiac troponin blood test which is the current gold standard for heart attack diagnosis may not .....
Scars in Women Reveal Undiagnosed Heart Attacks
Women once considered low risk for heart disease show evidence of previous heart attack scars. ......
Routine Medical Tests may Fail to Diagnose Heart Attacks
Unrecognized heart attacks that are missed in standard medical tests can be picked up by ......
Cardiovascular Disease: Immune Response to Heart Attacks
Cardiovascular diseases could be the immune system's response to heart attacks. Activation of ......
Aortic Valve Stenosis
Aortic valve Stenosis is an abnormal narrowing of the c valve. Symptoms include angina, and that of ...
Mitral Valve Prolapse
Mitral Valve Prolapse is a relatively common condition and causes leakage of blood through the valve...
Pericarditis
Pericarditis occurs when the pericardium gets inflamed. Pericarditis is characterized by severe ches...
Statins
Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms bu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use